Mounjaro approved for blood glucose control in type 2 diabetes

Mounjaro (tirzepatide) injection was approved as an addition to diet and exercise to improve blood glucose control in adults with type 2 diabetes, the U.S. Food and Drug Administration announced May 13.

source https://medicalxpress.com/news/2022-05-mounjaro-blood-glucose-diabetes.html